We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+17.82%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$9.2B
AUM Growth
+$666M
(+7.8%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-4.03%
Top 10 Holdings %
Top 10 Hldgs %
15.2%
Holding
729
New
149
Increased
136
Reduced
152
Closed
262
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ovintiv
OVV
|
+$112M |
| 2 |
TE Connectivity
TEL
|
+$108M |
| 3 |
Amazon
AMZN
|
+$79.4M |
| 4 |
Murphy Oil
MUR
|
+$69.6M |
| 5 |
Qorvo
QRVO
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$238M |
| 2 |
Electronic Arts
EA
|
+$107M |
| 3 |
Autodesk
ADSK
|
+$95.8M |
| 4 |
STMicroelectronics
STM
|
+$82.2M |
| 5 |
Keysight
KEYS
|
+$75.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.48% |
| 2 | Technology | 23.79% |
| 3 | Industrials | 10.38% |
| 4 | Energy | 8.46% |
| 5 | Consumer Discretionary | 6.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Ascendis Pharma A/S
ASND
$16B
| $2.03M | 0.02% |
+16,149
| New | +$1.61M |
|
|
JAMF
377
DELISTED
Jamf
JAMF
| $1.97M | 0.02% |
109,289
-479,285
| -81% | -$8.09M |
|
378
Erasca
ERAS
$6.46B
| $1.96M | 0.02% |
919,119
+795,546
| +644% | +$1.68M |
|
|
CEM
379
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
| $1.93M | 0.02% |
48,233
-177,512
| -79% | -$6.48M |
|
380
Flowserve
FLS
$10B
| $1.9M | 0.02% |
46,056
-129,061
| -74% | -$4.96M |
|
381
Trade Desk
TTD
$8.91B
| $1.85M | 0.02% |
+25,745
| New | +$1.89M |
|
382
Vita Coco
COCO
$3.75B
| $1.83M | 0.02% |
71,277
-195,472
| -73% | -$5.31M |
|
383
Seres Therapeutics
MCRB
$49.8M
| $1.81M | 0.02% |
64,514
+54,514
| +545% | +$1.43M |
|
384
SkinHealth Systems
SKIN
$91.4M
| $1.75M | 0.02% |
+562,903
| New | +$2.11M |
|
|
KLRS
385
Kalaris Therapeutics
KLRS
$99.7M
| $1.71M | 0.02% |
109,174
+19,319
| +22% | +$762K |
|
386
Coherus Oncology
CHRS
$224M
| $1.67M | 0.02% |
500,000
| – | – |
|
387
Curtiss-Wright
CW
$27.6B
| $1.66M | 0.02% |
+7,429
| New | +$1.55M |
|
388
Sagimet Biosciences
SGMT
$534M
| $1.63M | 0.02% |
300,169
-2
| -0% | -$9 |
|
389
Broadridge
BR
$18.6B
| $1.6M | 0.02% |
7,781
-12,893
| -62% | -$2.38M |
|
390
Warby Parker
WRBY
$3.59B
| $1.51M | 0.02% |
+106,966
| New | +$1.33M |
|
391
Mineralys Therapeutics
MLYS
$2.37B
| $1.5M | 0.02% |
175,000
| – | – |
|
392
Fate Therapeutics
FATE
$303M
| $1.44M | 0.02% |
+385,364
| New | +$910K |
|
393
Jasper Therapeutics
JSPR
$22M
| $1.37M | 0.01% |
173,299
-126,701
| -42% | -$850K |
|
394
Evolent Health
EVH
$346M
| $1.35M | 0.01% |
+40,957
| New | +$1.16M |
|
395
Krispy Kreme
DNUT
$534M
| $1.34M | 0.01% |
88,937
-116,775
| -57% | -$1.54M |
|
|
INZY
396
DELISTED
Inozyme Pharma
INZY
| $1.28M | 0.01% |
+300,000
| New | +$1.07M |
|
397
Eledon Pharmaceuticals
ELDN
$266M
| $1.24M | 0.01% |
689,340
+85,347
| +14% | +$119K |
|
398
Cirrus Logic
CRUS
$6.53B
| $1.23M | 0.01% |
+14,727
| New | +$1.1M |
|
|
CNTA
399
DELISTED
Centessa Pharmaceuticals
CNTA
| $1.12M | 0.01% |
140,856
-69,348
| -33% | -$465K |
|
400
Vertex Pharmaceuticals
VRTX
$123B
| $1.12M | 0.01% |
+2,742
| New | +$1.01M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Woodline Partners held 729 positions worth $9.2B, up 7.8% from $8.53B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners withdrew a net $371M in Q4 2023, closing 262 positions and reducing 152 holdings. Its most notable exit was Activision Blizzard, an estimated $238M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in Amazon worth $86M.
- Woodline Partners's largest Q4 2023 buy was Amazon: 566,298 shares worth $86M.
- Woodline Partners added most to Ovintiv in Q4 2023, an estimated $112M increase.
- Woodline Partners's biggest Q4 2023 reduction was Keysight, cutting an estimated $75.3M.
- Woodline Partners fully exited Activision Blizzard in Q4 2023, selling an estimated $238M.
- Woodline Partners's ten largest holdings make up 15% of its $9.2B portfolio in Q4 2023.
- Woodline Partners opened 149 new positions and closed 262 in Q4 2023.
- Woodline Partners's portfolio value rose 7.8% quarter-over-quarter to $9.2B.
Based on Woodline Partners's 13F filing for Q4 2023, filed 14 Feb 2024.